S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Immunomedics Announces European Orphan Drug Designation for Isactuzumab Govitecan for Pancreatic Cancer Treatment|
|Immunomedics Receives Third Edison Patent Award From Research & Development Council of New Jersey|
|Immunomedics Presents Clinical Data on Novel Antibody-Drug Conjugates for Solid Cancer Therapy|
|Immunomedics Announces Outcome of 2014 Annual Meeting of Stockholders|
|Immunomedics Announces Presentations at the 2014 European Association of Nuclear Medicine Congress|
|Immunomedics to Present Updated Clinical Results With Solid-Tumor Antibody-Drug Conjugates at Upcoming Conferences|
|Immunomedics Announces Conference Call and Webcast for First Quarter Fiscal 2015 Financial Results|
|Immunomedics Provides Update on Phase 2 Study of Isactuzumab Govitecan in Patients With Diverse Metastatic Solid Cancers|
|Immunomedics Announces Six Presentations on Epratuzumab in Lupus at Leading Rheumatology Meeting|
|Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Pemphigus|
Click above to view more mutual fund data and stats for immu - Immunomedics Inc.